STAT Plus: Pharmalittle: BioNTech expects to seek approval for vaccine by year-end; why the FDA chose a 50% threshold for Covid-19 vaccines
Peter Marks, a top FDA official, shed light on the reasoning behind the agency's choice of a 50% efficacy threshold for a Covid-19 vaccine.
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may
